These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 29295922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling.
    Koh W, Mahan RD, Davis GE.
    J Cell Sci; 2008 Apr 01; 121(Pt 7):989-1001. PubMed ID: 18319301
    [Abstract] [Full Text] [Related]

  • 11. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
    Pandey A, Dan I, Kristiansen TZ, Watanabe NM, Voldby J, Kajikawa E, Khosravi-Far R, Blagoev B, Mann M.
    Oncogene; 2002 May 30; 21(24):3939-48. PubMed ID: 12032833
    [Abstract] [Full Text] [Related]

  • 12. The Cdc42 Effector Kinase PAK4 Localizes to Cell-Cell Junctions and Contributes to Establishing Cell Polarity.
    Selamat W, Tay PL, Baskaran Y, Manser E.
    PLoS One; 2015 May 30; 10(6):e0129634. PubMed ID: 26068882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional cross-talk between Cdc42 and two downstream targets, Par6B and PAK4.
    Jin D, Durgan J, Hall A.
    Biochem J; 2015 Apr 15; 467(2):293-302. PubMed ID: 25662318
    [Abstract] [Full Text] [Related]

  • 15. Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein.
    Abdul-Manan N, Aghazadeh B, Liu GA, Majumdar A, Ouerfelli O, Siminovitch KA, Rosen MK.
    Nature; 1999 May 27; 399(6734):379-83. PubMed ID: 10360578
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. N-terminal interaction domain implicates PAK4 in translational regulation and reveals novel cellular localization signals.
    Baldassa S, Calogero AM, Colombo G, Zippel R, Gnesutta N.
    J Cell Physiol; 2010 Sep 27; 224(3):722-33. PubMed ID: 20578242
    [Abstract] [Full Text] [Related]

  • 18. Residues in Cdc42 that specify binding to individual CRIB effector proteins.
    Owen D, Mott HR, Laue ED, Lowe PN.
    Biochemistry; 2000 Feb 15; 39(6):1243-50. PubMed ID: 10684602
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors.
    Kast DJ, Yang C, Disanza A, Boczkowska M, Madasu Y, Scita G, Svitkina T, Dominguez R.
    Nat Struct Mol Biol; 2014 Apr 15; 21(4):413-22. PubMed ID: 24584464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.